MeridianConsensus
Operator profileHercules, CAData as of May 2026

Bio-Rad Laboratories

Bio-Rad Laboratories is American life science research firm. Founded in 1952. Approximately 8,300 employees. (Wikidata)

Bio-Rad Laboratories's strongest tracked position is the Affinity Chromatography Market at an estimated 10.0% share in a market growing at 7.2% CAGR.

Meridian Consensus tracks Bio-Rad Laboratories in 1 market across 1 industry (Healthcare). Estimated in-market revenue is $425M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Filed financials · SEC 10-K · FY2025

EDGAR · CIK 12208
Revenue (filed)
$2.6B
Net income (filed)
$760M
Total assets (filed)
$10.6B

Exchange-filed figures from SEC XBRL companyfacts (BIO-RAD LABORATORIES, INC.). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.

Markets tracked
1
Industries
1
Est. in-market revenue
$425M
Top market share
10.0%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

MarketCAGRShare
Affinity Chromatography Market7.2%10.0%

Meridian Dossier

Need diligence-grade depth on Bio-Rad Laboratories?

Commission a source-cited diligence dossier on Bio-Rad Laboratories: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

Bio-Rad Laboratories: frequently asked

Meridian Consensus tracks Bio-Rad Laboratories in 1 market: Affinity Chromatography Market ($4.2B), spanning Healthcare.

Bio-Rad Laboratories's strongest tracked position is the Affinity Chromatography Market, a $4.2B market growing at 7.2% CAGR, where it holds an estimated 10.0% share as of May 2026.

Across Meridian-tracked markets, Bio-Rad Laboratories's closest peers are Cytiva, Thermo Fisher, Merck KGaA, Sartorius, Tosoh Corporation, with the largest overlap in the Affinity Chromatography Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in Healthcare

Tracked markets in the same industry where Bio-Rad Laboratories is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with Bio-Rad Laboratories

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.